Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The Umberto Veronesi Milan Breast Cancer Conference /
Low dose exemestane usage in breast cancer

22nd - 23rd Jun 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.06.17
Views: 1249

Dr Davide Serrano - European Institute of Oncology, Milan, Italy

Dr Serrano talks with ecancer at The Umberto Veronesi Milan Breast Cancer Conference about breast cancer prevention techniques and his aim to reduce the number of instances of the disease. He discusses the potential risk factors and looks at some preventative action that can be taken. 

Dr Serrano goes onto talk about the ongoing multi-centre trial looking at ER positive breast cancer and substituting low dose exemestane, a aromatase inhibitor, for tamoxifen. 

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation